ORF35 - When Remission Is Not Enough: Optimizing Outcomes in Cushing’s Disease

Sunday, June 14, 2026

3:30 PM - 4:15 PM CT

Location: Room W187

ORF Chair-Primary(s)

Karen Miller, MD (she/her/hers)

Massachusetts Gen Hospital
Boston, MA, United States

Disclosure(s): Amgen: Grant Recipient (); Becton Dickinson: Stockholder (); Boston Scientific: Stockholder (); Bristol Myers Squibb: Stockholder (); GE Healthcare: Stockholder ()
AL

Alice Levine, MD

Prof of Med
Mt Sinai Medical Center
New York, NY, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Karen K. Miller, MD: Amgen: Grant Recipient (); Becton Dickinson: Stockholder (); Boston Scientific: Stockholder (); Bristol Myers Squibb: Stockholder (); GE Healthcare: Stockholder ()

Alice Levine, MD: No financial relationships to disclose